Page 19 - World Journal of Laparoscopic Surgery
P. 19

Comparative Study of the Effect of Various Bariatric Surgery Methods
              2.  Pi-Sunyer FX. Comorbidities of overweight and obesity: current     15.  Aldoheyan T, Hassanain M, Al-Mulhim A, et al. The effects of
                evidence and research issues. Med Sci Sports Exerc 1999;31(Suppl.   bariatric surgeries on nonalcoholic fatty liver disease. Surg Endosc
                11):S602–S608. DOI: 10.1097/00005768-199911001-00019.  2017;31(3):1142–1147. DOI: 10.1007/s00464-016-5082-8. 
              3.  Fabbrini E, Sullivan S, Klein S. Obesity and non-alcoholic fatty     16.  Kalinowski P, Paluszkiewicz R, Ziarkiewicz–Wróblewska B, et al. Liver
                liver disease: biochemical, metabolic, and clinical implications.   function in patients with nonalcoholic fatty liver disease randomized
                Hepatology 2010;51(2):679–689. DOI: 10.1002/hep.23280.  to Roux-en-Y gastric bypass versus sleeve gastrectomy: a secondary
              4.  Fisher BL, Schauer P. Medical and surgical options in the treatment   analysis of a randomized clinical trial. Ann Surg 2017;266(5):738–745.
                of severe obesity. Am J Surg 2002;184(6):S9–S16. DOI: 10.1016/s0002-  DOI: 10.1097/SLA.0000000000002397.
                9610(02)01173-x.                                 17.  Ruiz–Tovar J, Muñoz JL, Gonzalez J, et al. Postoperative pain after
              5.  DeMaria EJ, Jamal MK. Surgical options for obesity. Gastroenterology   laparoscopic sleeve gastrectomy: comparison of three analgesic
                Clinics. 2005;34(1):127–142. DOI: 10.1016/j.gtc.2004.12.005.  schemes (isolated intravenous analgesia, epidural analgesia
              6.  Cannon CP, Kumar A. Treatment of overweight and obesity:   associated with intravenous analgesia and port-sites infiltration with
                lifestyle, pharmacologic, and surgical options. Clinical cornerstone.   bupivacaine associated with intravenous analgesia). Surg Endosc
                2009;9(4):55–68.  DOI: 10.1016/s1098-3597(09)80005-7.  2017;31(1):231–236. DOI: 10.1007/s00464-016-4961-3.
               7.  Chavez–Tapia NC, Tellez–Avila FI, Barrientos–Gutierrez T, et al. Bariatric     18.  Manco M, Mosca A, De Peppo F, et al. The benefit of sleeve gas-
                surgery for non‐alcoholic steatohepatitis in obese patients. Cochrane   trectomy in obese adolescents on nonalcoholic steatohepatitis
                Database Syst Rev 2010(1): CD007340. DOI: 10.1002/14651858.  and hepatic fibrosis. J Pediatr 2017;180:31.e2–7.e2. DOI: 10.1016/j.
                CD007340.pub2.                                      jpeds.2016.08.101.
              8.  Angulo P. Nonalcoholic fatty liver disease. New Eng J Med     19.  Nascimento TM, Alves–Junior A, Nunes MAP, et al. Comparison of
                2002;346(16):1221–1231. DOI: 10.1056/NEJMra011775.  hepatic profile in pre and postoperative of bariatric surgery: private
              9.  Williams CD, Stengel J, Asike MI, et al. Prevalence of nonalcoholic   vs public network. Arq Bras Cir Dig 2015;28(4):274–277. DOI: 10.1590/
                fatty liver disease and nonalcoholic steatohepatitis among a largely   S0102-6720201500040014.
                middle-aged population utilizing ultrasound and liver biopsy:     20.  Kenneally S, Sier JH, Moore JB. Efficacy of dietary and physical activity
                a prospective study. Gastroenterology 2011;140(1):124–131. DOI:   intervention in non-alcoholic fatty liver disease: a systematic review.
                10.1053/j.gastro.2010.09.038.                       BMJ Open Gastroenterol 2017;4(1):e000139. DOI: 10.1136/bmjgast-
              10.  Angulo P, Hui JM, Marchesini G, et al. The NAFLD fibrosis score: a   2017-000139.
                noninvasive system that identifies liver fibrosis in patients with     21.  Kral JG, Thung SN, Biron S, et al. Effects of surgical treatment of
                NAFLD. Hepatology 2007;45(4):846–854. DOI: 10.1002/hep.21496.  the metabolic syndrome on liver fibrosis and cirrhosis. Surgery
              11.  Hassanain M, Aldoheyan T, Alsabhan A, et al. The effects of bariatric   2004;135(1):48–58. DOI: 10.1016/j.surg.2003.10.003.
                surgeries on non-alcoholic fatty liver disease. HPB. 2016;18:e242–e243.    22.  Major P, Pędziwiatr M, Rubinkiewicz M, et al. Impact of bariatric
              12.  Ooi GJ, Burton PR, Doyle L, et al. Effects of bariatric surgery on liver   surgery on non-alcoholic fatty liver disease. Pol Przegl Chir
                function tests in patients with nonalcoholic fatty liver disease. Obes   2017;89(2):1–4. DOI: 10.5604/01.3001.0009.6003.
                Surg 2017;27(6):1533–1542. DOI: 10.1007/s11695-016-2482-8.    23.  Billeter AT, Senft J, Gotthardt D, et al. Combined nonalcoholic fatty
              13.  Karcz WK, Krawczykowski D, Küsters S, et al. Influence of sleeve   liver disease and type 2 diabetes mellitus: sleeve gastrectomy or
                gastrectomy on NASH and type 2 diabetes mellitus. Journal of   gastric bypass?—a controlled matched pair study of 34 patients.
                obesity. 2011;2011:765473. DOI: 10.1155/2011/765473.  Obes Surg 2016;26(8):1867–1874. DOI: 10.1007/s11695-015-2006-y.
              14.  Kasper DL, Harrison TR. Harrison’s Principles of Internal Medicine.     24.  Schulz PO, Ferreira FG, Nascimento MdFA, et al. Association of
                Univerza v Ljubljani, Medicinska fakulteta; 2012. Chapter 395, 19th   nonalcoholic fatty liver disease and liver cancer. World J Gastroenterol
                edition, pp. 2849–2850.                             2015;21(3):913–918. DOI: 10.3748/wjg.v21.i3.913.





































                                                        World Journal of Laparoscopic Surgery, Volume 15 Issue 2 (May–August 2022)  115
   14   15   16   17   18   19   20   21   22   23   24